tiprankstipranks
Trending News
More News >
Impact BioMedical, Inc. (IBO)
:IBO
US Market

Impact BioMedical, Inc. (IBO) Financial Statements

Compare
101 Followers

Impact BioMedical, Inc. Financial Overview

Impact BioMedical, Inc.'s market cap is currently ―. The company's EPS TTM is $-2.159; its P/E ratio is -0.13; Impact BioMedical, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total RevenueC$ 2.33MC$ 0.00C$ 50.00KC$ 50.00KC$ 0.00
Gross ProfitC$ 2.33MC$ 0.00C$ 50.00KC$ 50.00KC$ 0.00
Operating IncomeC$ 551.66KC$ -4.03MC$ -3.40MC$ -3.40MC$ -1.14M
EBITDAC$ -1.54MC$ -2.84MC$ -6.30MC$ -6.30MC$ 0.00
Net IncomeC$ -2.05MC$ -4.34MC$ -7.05MC$ -7.05MC$ -760.07K
Balance Sheet
Cash & Short-Term InvestmentsC$ 2.00MC$ 1.00KC$ 2.00KC$ 46.00KC$ 52.14K
Total AssetsC$ 20.29MC$ 44.63MC$ 46.50MC$ 56.42MC$ 72.74K
Total DebtC$ 8.88MC$ 12.07MC$ 9.99MC$ 12.52MC$ 60.00K
Net DebtC$ 6.88MC$ 12.07MC$ 9.99MC$ 12.48MC$ 7.86K
Total LiabilitiesC$ 13.05MC$ 16.37MC$ 13.83MC$ 16.50MC$ 78.03K
Stockholders' EquityC$ 4.26MC$ 25.22MC$ 29.56MC$ 36.61MC$ -5.28K
Cash Flow
Free Cash FlowC$ -5.64MC$ -2.87MC$ -4.43MC$ -3.25MC$ -1.14K
Operating Cash FlowC$ -5.64MC$ -2.85MC$ -4.33MC$ -3.25MC$ -1.14K
Investing Cash FlowC$ 2.88KC$ -15.00KC$ -2.09MC$ -42.93KC$ -804.00
Financing Cash FlowC$ 8.51MC$ 2.87MC$ 7.01MC$ 3.38MC$ 1.90K
Currency in CAD

Impact BioMedical, Inc. Earnings and Revenue History

Impact BioMedical, Inc. Debt to Assets

Impact BioMedical, Inc. Cash Flow

Impact BioMedical, Inc. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.